High-throughput sequencing assays face persistent challenges when analyzing low-quality RNAs, often assessed by the RNA integrity number (RIN). Current preprocessing methods and pipelines designed for mRNA-seq presume high-quality RNAs, overlooking the nuanced complexities arising from degraded transcripts in low-quality samples. This study questions the applicability of standard analysis pipelines, especially when sequencing low-quality total RNAs, which are sometimes the sole recourse for specific inquiries. To address this, we conducted a comprehensive investigation using large sequencing reads obtained from blood biospecimens with varying RINs. Introducing a novel mapping approach, termed 'stepwise mapping', our systematic comparative analyses propose an optimal practice for total RNA-seq data analysis. Contrary to conventional mapping procedures, the 'stepwise mapping' approach unveils additional transcriptome information, crucial for stable differential expression analysis, even with total RNA-seq data from specimens with relatively low RINs. Our method proves particularly valuable when analyzing limited specimens with low RNA quality.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: